Loading...
Indian Pharmaceutical Exporter · #10 for Glimepiride · $882.8K export value · DGFT Verified
Aurobindo Pharma Ltd is the #10 Indian exporter of Glimepiride with $882.8K in export value and 203 verified shipments. Aurobindo Pharma Ltd holds a 1.2% market share in Glimepiride exports across 3 countries.
Aurobindo Pharma Ltd exports Glimepiride to 4 countries. The largest destination is MALTA accounting for 69.9% of Aurobindo Pharma Ltd's Glimepiride shipments, followed by FRANCE (26.6%) and TANZANIA (3.0%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $286.8K | 109 |
| ARROW GENERIQUES, | FRANCE | $77.6K | 79 |
| ARROW GENERIQUES | FRANCE | $51.5K | 30 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $20.0K | 17 |
| APL SWIFT SERVICES MALTA LIMITED | MALTA | $19.2K | 33 |
| GENERICS & SPECIALITIES LTD, | TANZANIA | $15.4K | 2 |
| APL SWIFT SERVICES (MALTA) LIMITED | MALTA | $14.6K | 10 |
| APL SWIFT SERVICES (MALTA) LIMITED, | MALTA | $13.8K | 37 |
| APL SWIFT SERVICES (MALTA) LTD | MALTA | $3.5K | 9 |
| ARROW GENERIQUES - FR | FRANCE | $3.1K | 1 |
Aurobindo Pharma Ltd supplies Glimepiride to 13 buyers globally. The largest buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by ARROW GENERIQUES, (FRANCE) and ARROW GENERIQUES (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $23.4M worth of Glimepiride through 3,159 shipments from 242 suppliers to 94 countries, serving 535 buyers globally. Aurobindo Pharma Ltd contributes $882.8K to this total, accounting for 1.2% of India's Glimepiride exports. Aurobindo Pharma Ltd ships Glimepiride to 4 countries through 13 buyers.
Aurobindo Pharma Ltd's average Glimepiride shipment value is $4.3K per consignment, based on 203 shipments totaling $882.8K. The largest destination is MALTA (69.9% of Aurobindo Pharma Ltd's Glimepiride exports).
Aurobindo Pharma Ltd ranks #10 among 242 Indian Glimepiride exporters with a 1.2% market share. The top 3 exporters are MICRO LABS LIMITED ($5.3M), IPCA LABORATORIES LIMITED ($3.6M), INVENTIA HEALTHCARE LIMITED ($3.0M). Aurobindo Pharma Ltd processed 203 shipments to 3 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GLIMEPRIDE TABLETS 2MG(Glimepiride Aurob | $120.3K | 14 |
| GLIMEPRIDE TABLETS 3MG(Glimepiride Aurob | $118.8K | 15 |
| GLIMEPRIDE TABLETS 4MG(Glimepiride Aurob | $20.0K | 8 |
| GLIMIPRIDE 4 MG TABLETS(GLIMEPIRIDE ARRO | $16.8K | 6 |
| GLIMIPRIDE 3 MG TABLETS(GLIMEPIRIDE ARRO | $11.6K | 6 |
| GLIMEPIRIDE TABLETS 2 MG (GLIMSURE 2) 30'S (5880 Packs) | $8.3K | 1 |
| GLIMEPIRIDE TABLETS 2MG, 4704 PACKS OF 30'S (AS PER INVOICE) | $7.1K | 1 |
| GLIMIPRIDE 2 MG TABLETS(GLIMEPIRIDE ARRO | $6.3K | 4 |
| GLIMIPRIDE 3 MG TABLETS (GLIMEPIRIDE ARR | $6.2K | 3 |
| GLIMEPRIDE TABLETS 3MGGlimepiride Aurobindo 3 mg, tabletten30'S | $5.9K | 3 |
Aurobindo Pharma Ltd exports 174 distinct Glimepiride formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GLIMEPRIDE TABLETS 2MG(Glimepiride Aurob with 14 shipments worth $120.3K.
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | MYLAN LABORATORIES LIMITED | $1.3M | 86 | 4 | $14.8K |
| 9 | AJANTA PHARMA LIMITED | $1.2M | 41 | 3 | $28.4K |
| 10 | AUROBINDO PHARMA LTD ★ | $882.8K | 203 | 3 | $4.3K |
| 13 | ZENTIVA PRIVATE LIMITED | $693.1K | 38 | 1 | $18.2K |
| 14 | AZTEC PHARMA PRIVATE LIMITED | $607.9K | 25 | 1 | $24.3K |
Aurobindo Pharma Ltd ranks #10 among 242 Indian Glimepiride exporters. Average shipment value of $4.3K compared to the market average of $96.6K. The closest competitors by value are MYLAN LABORATORIES LIMITED and AJANTA PHARMA LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 350 | 11.1% |
| NHAVA SHEVA SEA (INNSA1) | 268 | 8.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 241 | 7.6% |
| DELHI AIR CARGO ACC (INDEL4) | 228 | 7.2% |
| DELHI AIR | 226 | 7.2% |
| JNPT/ NHAVA SHEVA SEA | 172 | 5.4% |
| BANGALORE ACC (INBLR4) | 148 | 4.7% |
| BANGALORE AIR | 110 | 3.5% |
Latest developments and market context
Detailed market intelligence for Glimepiride — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 535+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Glimepiride exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glimepiride. For current shipment-level data, contact TransData Nexus.